BeOne Medicines Ltd. (ONC) income statement
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302532% above fair value
$390.94−8.76 (-2.19%)
Close on Nov 20, 2026Market cap $44.45BP/E 69.9Yield –
BeOne Medicines Ltd. financial ratios
See a number that looks wrong?